🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Denmark / NCT06537804
Active, not recruiting Not applicable

Project Lung Cancer Screening in Southern Denmark

NCT06537804 · tracked via the Priya Life Science Denmark tracker
Phase
Not applicable
Started
2024-08-05
Last updated
2025-04-15

Condition(s) studied

Lung Cancer

Investigational drug(s) / intervention(s)

Screening by low-dose CT scan

Screening by low-dose CT scan: Screening for lung cancer by low-dose CT scan

Study summary

One thousand randomly selected voluntary citizens aged 60-74 years old, who are heavy current or former smokers with an increased risk of developing lung cancer may be included in the project. The participants will be identified through an initial questionnaire survey concerning smoking history and general health. Project participants are offered a low-dose CT (LDCT) scan annually for three consecutive years. In relation to the first scan, a lung function test will also be performed. The screening process will be evaluated for possible national implementation of a lung cancer screening program in Denmark.

Eligibility

Sex
ALL
Min age
60 Years
Max age
74 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Heavy smokers (≥ 30 pack years) or citizens with a PLCOm2012 calculated 6-year risk of lung cancer \> 2%. * Age: 60-74 years old * Residence on Funen and surrounding islands Exclusion Criteria: * Cancer treatment or follow-up (except non melanoma skin cancer and similar low malignant cancers) within the past 12 months * CT scan performed within the past 12 months

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Odense University Hospital Odense Region Syddanmark
Department of Radiology, Svendborg Hospital Svendborg Region Syddanmark

More Odense University Hospital trials in Denmark

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06537804 on ClinicalTrials.gov ↗ ← All trials in Denmark